Advanced Solid Tumor

Oncology·MeSH: Neoplasm Metastasis

316 drugs in development·99 companies·116 clinical trials

Drug Pipeline by Phase

Phase 3(40)

Drug	Company
an2025	Adlai Nortye Ltd. (ANL)
anticancer agents	BeOne Medicines Ltd. (ONC)
Anticancer Agents	BeOne Medicines Ltd. (ONC)
azd3470	ASTRAZENECA PLC (AZN)
AZD5069	ASTRAZENECA PLC (AZN)
AZD9150	ASTRAZENECA PLC (AZN)
bgb-15025	BeOne Medicines Ltd. (ONC)
BGB-15025	BeOne Medicines Ltd. (ONC)
bgb-43395	BeOne Medicines Ltd. (ONC)
bgb-43395	BeOne Medicines Ltd. (ONC)
BGB-43395	BeOne Medicines Ltd. (ONC)
bgb-b455	BeOne Medicines Ltd. (ONC)
BGB-B455	BeOne Medicines Ltd. (ONC)
BGB-C354	BeOne Medicines Ltd. (ONC)
cemiplimab+fianlimab fixed dose combination	REGENERON PHARMACEUTICALS, INC. (REGN)
chemotherapy	BeOne Medicines Ltd. (ONC)
Chemotherapy	BeOne Medicines Ltd. (ONC)
DB-1305/BNT325	BioNTech SE (BNTX)
elironrasib	REVOLUTION MEDICINES, INC. (RVMD)
fdc fianlimab+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
fruquintinib in combination with sintilimab	HUTCHMED (China) Limited (HCM)
inca00186	Incyte Corp. (INCY)
incb081776	Incyte Corp. (INCY)
incb106385	Incyte Corp. (INCY)
incmga00012	Incyte Corp. (INCY)
IV Rilvegostomig	ASTRAZENECA PLC (AZN)
LY3537982	ELI LILLY & Co (LLY)
MEDI4736	ASTRAZENECA PLC (AZN)
mFOLFIRINOX	Tango Therapeutics, Inc. (TNGX)
MK-3120	Merck & Co., Inc. (MRK)
mRNA-4359	Moderna, Inc. (MRNA)
regn15505+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
rp1 in combination with nivolumab	Replimune Group, Inc. (REPL)
SC Rilvegostomig	ASTRAZENECA PLC (AZN)
SC rilvegostomig + rHu	ASTRAZENECA PLC (AZN)
tebentafusp	Immunocore Holdings plc (IMCR)
tislelizumab	BeOne Medicines Ltd. (ONC)
Tislelizumab	BeOne Medicines Ltd. (ONC)
tsr-042	TESARO, Inc. (TSRO)
zoldonrasib	REVOLUTION MEDICINES, INC. (RVMD)

Phase 2(41)

Drug	Company
ACR-2316	Acrivon Therapeutics, Inc. (ACRV)
agen2373	AGENUS INC (AGEN)
alks 4230	Mural Oncology plc (MURA)
apl-102	Apollomics Inc. (APLM)
Bendamustine	FATE THERAPEUTICS INC (FATE)
BMS-986249	CytomX Therapeutics, Inc. (CTMX)
BMS-986288	CytomX Therapeutics, Inc. (CTMX)
BT5528	BICYCLE THERAPEUTICS PLC (BCYC)
Calcium folinate	BRISTOL MYERS SQUIBB CO (BMY)
capmatinib	Novartis AG (NVS)
capmatinib	Novartis AG (NVS)
CAR-T Cell Therapy	BeOne Medicines Ltd. (ONC)
Cediranib	ADMA BIOLOGICS, INC. (ADMA)
Cediranib	Merus N.V. (MRUS)
Cetrelimab	Janux Therapeutics, Inc. (JANX)
Enzalutamide	Novartis AG (NVS)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
Fludarabine	FATE THERAPEUTICS INC (FATE)
imm-1-104	Immuneering Corp (IMRX)
incb099280	Incyte Corp. (INCY)
incb099318	Incyte Corp. (INCY)
Interleukin-2	ENANTA PHARMACEUTICALS INC (ENTA)
Interleukin-2	Filana Therapeutics Inc. (FLNA)
LEE011	Novartis AG (NVS)
Lurbinectedin	Jazz Pharmaceuticals plc (JAZZ)
mirdametinib	SpringWorks Therapeutics, Inc. (SWTX)
navicixizumab	OncoMed Pharmaceuticals Inc (OMED)
nazartinib	Novartis AG (NVS)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
osimertinib	Novartis AG (NVS)
RP-1664	Repare Therapeutics Inc. (RPTX)
RP-3467	Repare Therapeutics Inc. (RPTX)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
rtx-240	Rubius Therapeutics, Inc. (RUBY)
solnerstotug	Sensei Biotherapeutics, Inc. (SNSE)
TransCon IL-2 β/γ	Ascendis Pharma A/S (ASND)
TransCon TLR7/8 Agonist	Ascendis Pharma A/S (ASND)
vobramitamab duocarmazine	MACROGENICS INC (MGNX)
Vobramitamab Duocarmazine (vobra duo)	MACROGENICS INC (MGNX)
vobramitamab duocarmazine 2.0 mg	MACROGENICS INC (MGNX)
vobramitamab duocarmazine 2.7 mg	MACROGENICS INC (MGNX)

Phase 1(155)

Drug	Company
[111in]-fpi-2107	ASTRAZENECA PLC (AZN)
[225ac]-fpi-2068	ASTRAZENECA PLC (AZN)
AB308	Arcus Biosciences, Inc. (RCUS)
AB521	EXELIXIS, INC. (EXEL)
ABBV-181	AbbVie Inc. (ABBV)
ABBV-368	AbbVie Inc. (ABBV)
Abiraterone	BioNTech SE (BNTX)
adagrasib	Incyte Corp. (INCY)
Aldesleukin	ENANTA PHARMACEUTICALS INC (ENTA)
amg 355	AMGEN INC (AMGN)
amg 436	AMGEN INC (AMGN)
an0025	Adlai Nortye Ltd. (ANL)
an4005-dose level 0	Adlai Nortye Ltd. (ANL)
an4005-dose level 1	Adlai Nortye Ltd. (ANL)
an4005-dose level 2	Adlai Nortye Ltd. (ANL)
an4005-dose level 3	Adlai Nortye Ltd. (ANL)
an4005-dose level 4	Adlai Nortye Ltd. (ANL)
an4005-food effect	Adlai Nortye Ltd. (ANL)
an8025 is a multifunctional antibody fusion protein	Adlai Nortye Ltd. (ANL)
anti-diarrheal agent	BeOne Medicines Ltd. (ONC)
anti-diarrheal agent	BeOne Medicines Ltd. (BEIGF)
Anti-PD-1 monoclonal antibody	iTeos Therapeutics, Inc. (ITOS)
Anticancer agent	iTeos Therapeutics, Inc. (ITOS)
APR-1051	Aprea Therapeutics, Inc. (APRE)
ASP1570	IGM Biosciences, Inc. (IGMS)
atg-101	HCW Biologics Inc. (HCWB)
ATRN-119	Aprea Therapeutics, Inc. (APRE)
bg-75098	BeOne Medicines Ltd. (ONC)
BG-75098	BeOne Medicines Ltd. (ONC)
bg-89894	BeOne Medicines Ltd. (ONC)
BG-89894	BeOne Medicines Ltd. (ONC)
bg-c0979	BeOne Medicines Ltd. (ONC)
BG-C0979	BeOne Medicines Ltd. (ONC)
bg-c137	BeOne Medicines Ltd. (ONC)
BG-C137	BeOne Medicines Ltd. (ONC)
bg-c477	BeOne Medicines Ltd. (ONC)
BG-C477	BeOne Medicines Ltd. (ONC)
BG-C477	Merus N.V. (MRUS)
bg-c9074	BeOne Medicines Ltd. (ONC)
BG-C9074	BeOne Medicines Ltd. (ONC)
bgb-26808	BeOne Medicines Ltd. (BEIGF)
bgb-26808	BeOne Medicines Ltd. (ONC)
bgb-58067	BeOne Medicines Ltd. (ONC)
BGB-58067	BeOne Medicines Ltd. (ONC)
bgm-2121	PRECISION BIOSCIENCES INC (DTIL)
blu-222	Blueprint Medicines Corp (BPMC)
BNT317 DL1	BioNTech SE (BNTX)
BNT317 DL2	BioNTech SE (BNTX)
BNT317 DL3	BioNTech SE (BNTX)
BNT317 DL4	BioNTech SE (BNTX)
BNT317 DL5	BioNTech SE (BNTX)
BNT317 DL6	BioNTech SE (BNTX)
BNT317 DL7	BioNTech SE (BNTX)
BNT326	Merus N.V. (MRUS)
brenetafusp	Immunocore Holdings plc (IMCR)
Brenetafusp and chemotherapy	Immunocore Holdings plc (IMCR)
Brenetafusp and kinase inhibitors	Immunocore Holdings plc (IMCR)
Brenetafusp and monoclonal antibodies and chemotherapy	Immunocore Holdings plc (IMCR)
Brenetafusp and tebentafusp	Immunocore Holdings plc (IMCR)
BT7480	BICYCLE THERAPEUTICS PLC (BCYC)
cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
chs-114	Coherus Oncology, Inc. (CHRS)
cln-418	Q BioMed Inc. (QBIO)
CLN-418	Cullinan Therapeutics, Inc. (CGEM)
CLN-619	Cullinan Therapeutics, Inc. (CGEM)
CTX-471	Compass Therapeutics, Inc. (CMPX)
CX-904	CytomX Therapeutics, Inc. (CTMX)
DB-1311	KYNTRA BIO INC. (KYNB)
drug	BeOne Medicines Ltd. (ONC)
Drug	BeOne Medicines Ltd. (ONC)
Efbalropendekin alfa (XmAb306 / RG6323)	Xencor Inc (XNCR)
elacestrant	BeOne Medicines Ltd. (ONC)
Elacestrant	BeOne Medicines Ltd. (ONC)
elzovantinib	Turning Point Therapeutics, Inc. (TPTX)
Enzalutamide	BioNTech SE (BNTX)
Enzalutamide	Nuvation Bio Inc. (NUVB)
EOS006215	iTeos Therapeutics, Inc. (ITOS)
EOS301984	iTeos Therapeutics, Inc. (ITOS)
felezonexor	STEMLINE THERAPEUTICS INC (STML)
FID-022	Fulgent Genetics Inc. (FLGT)
fpi-2053	ASTRAZENECA PLC (AZN)
FT825	FATE THERAPEUTICS INC (FATE)
gen1079	Genmab A/S (GMAB)
Granulocyte colony stimulating factor	IGM Biosciences, Inc. (IGMS)
gs-2121	GILEAD SCIENCES, INC. (GILD)
hbm1020	Q BioMed Inc. (QBIO)
hcb301	Turnstone Biologics Corp. (TSBX)
IMC-R117C (PIWIL-1)	Immunocore Holdings plc (IMCR)
Interleukin-2	Merus N.V. (MRUS)
itraconazole	KYNTRA BIO INC. (KYNB)
Itraconazole	Merus N.V. (MRUS)
jh021	West Pharmaceutical Services Inc. (WST)
JZP898	Jazz Pharmaceuticals plc (JAZZ)
KSQ-001EX	Filana Therapeutics Inc. (FLNA)
KSQ-001EX	ENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EX	Merus N.V. (MRUS)
KSQ-004EX	ENANTA PHARMACEUTICALS INC (ENTA)
KSQ-004EX	Filana Therapeutics Inc. (FLNA)
LB101	Centessa Pharmaceuticals plc (CNTA)
Lopinavir and Ritonavir Tablets	BioNTech SE (BNTX)
loxo-292	LOXO ONCOLOGY, INC. (LOXO)
M0324	Merus N.V. (MRUS)
M0324	Tango Therapeutics, Inc. (TNGX)
M0324	Merck & Co., Inc. (MRK)
M3554	Merck & Co., Inc. (MRK)
M9466	IGM Biosciences, Inc. (IGMS)
mFOLFIRINOX	Merck & Co., Inc. (MRK)
MGC026	MACROGENICS INC (MGNX)
MGC026 Dose Escalation	MACROGENICS INC (MGNX)
MGC026 Dose for Expansion	MACROGENICS INC (MGNX)
MGC028	MACROGENICS INC (MGNX)
mnpr-101-lu	Monopar Therapeutics (MNPR)
mnpr-101-zr	Monopar Therapeutics (MNPR)
NT-I7	Merck & Co., Inc. (MRK)
NUV-1511	Nuvation Bio Inc. (NUVB)
NUV-868	Nuvation Bio Inc. (NUVB)
NUV-868	KYNTRA BIO INC. (KYNB)
NVL-330	Nuvalent, Inc. (NUVL)
nxp800	Nuvectis Pharma, Inc. (NVCT)
nxp900	Nuvectis Pharma, Inc. (NVCT)
Olaparib	Nuvation Bio Inc. (NUVB)
Olaparib 200-300 mg BID, daily	Repare Therapeutics Inc. (RPTX)
omtx705	GT Biopharma, Inc. (GTBP)
other therapeutic agents	BeOne Medicines Ltd. (ONC)
Other Therapeutic Agents	BeOne Medicines Ltd. (ONC)
panitumumab	AMGEN INC (AMGN)
Paroxetine	Merus N.V. (MRUS)
PD-L1 t-haNK	ImmunityBio, Inc. (IBRX)
Pertuzumab Injection	BioNTech SE (BNTX)
promitil	Rafael Holdings, Inc. (RFL)
prt3789	Prelude Therapeutics Inc (PRLD)
prt7732	Prelude Therapeutics Inc (PRLD)
pt-112	SCICLONE PHARMACEUTICALS INC (SCLN)
qtx3046	QUANTA INC (QNTA)
qtx3544	QUANTA INC (QNTA)
Recombinant Human Hyaluronidase	ASTRAZENECA PLC (AZN)
Ritonavir	BioNTech SE (BNTX)
RP-3467 at assigned dose and schedule	Repare Therapeutics Inc. (RPTX)
RP-6306	IGM Biosciences, Inc. (IGMS)
RP3	Replimune Group, Inc. (REPL)
sim0505	NextCure, Inc. (NXTC)
sl-801	STEMLINE THERAPEUTICS INC (STML)
sqz-pbmc-hpv	SQZ Biotechnologies Co (SQZB)
sw-682	SpringWorks Therapeutics, Inc. (SWTX)
Talazoparib	Repare Therapeutics Inc. (RPTX)
tcrt-eso-a2	Athenex, Inc. (ATNX)
tev-56278	Teva Pharmaceutical Industries Limited (TEVA)
Tilsotolimod	AbbVie Inc. (ABBV)
tislelizumab	GT Biopharma, Inc. (GTBP)
tpx-0046	Turning Point Therapeutics, Inc. (TPTX)
Trifluridine + Tipiracil	IGM Biosciences, Inc. (IGMS)
tsr-022	TESARO, Inc. (TSRO)
XmAb808	Xencor Inc (XNCR)
Zimberelimab	Arcus Biosciences, Inc. (RCUS)
zw191	Zymeworks Inc. (ZYME)

Preclinical(4)

Drug	Company
chs-1000	Coherus Oncology, Inc. (CHRS)
gsk4381562	Coherus Oncology, Inc. (CHRS)
gtb-5550	GT Biopharma, Inc. (GTBP)
mnpr-101-ac	Monopar Therapeutics (MNPR)

Phase 1/Phase 2(66)

Drug	Company
anti pd-1/l1	AMGEN INC (AMGN)
apg-1387	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
bgb-3245	SpringWorks Therapeutics, Inc. (SWTX)
blu-924	Blueprint Medicines Corp (BPMC)
BNT3212	BioNTech SE (BNTX)
bnt3214	BioNTech SE (BNTX)
BNT326	BioNTech SE (BNTX)
BNT327	BioNTech SE (BNTX)
cemiplimab	VERTEX PHARMACEUTICALS INC / MA (VRTX)
cetuximab	AC Immune SA (ACIU)
cetuximab	REVOLUTION MEDICINES, INC. (RVMD)
CGT4255	Cogent Biosciences, Inc. (COGT)
chemotherapy	Ascendis Pharma A/S (ASND)
Chemotherapy drug	Ascendis Pharma A/S (ASND)
combination therapy	SpringWorks Therapeutics, Inc. (SWTX)
dcc-3084	Deciphera Pharmaceuticals, Inc. (DCPH)
envometinib	Immuneering Corp (IMRX)
gen1079	GENMAB A/S (GNMSF)
gen1286	GENMAB A/S (GNMSF)
gen1286	Genmab A/S (GMAB)
gi-101	Innovation Pharmaceuticals Inc. (IPIX)
gi-101a	Innovation Pharmaceuticals Inc. (IPIX)
gi-108	Innovation Pharmaceuticals Inc. (IPIX)
hec169096	SUNSHINE BIOPHARMA INC. (SBFM)
imc-r117c	Immunocore Holdings plc (IMCR)
imm-1-104 + dabrafenib	Immuneering Corp (IMRX)
imm-1-104 + modified folfirinox	Immuneering Corp (IMRX)
imm-1-104 monotherapy	Immuneering Corp (IMRX)
imm-6-415	Immuneering Corp (IMRX)
imp1734	Eikon Therapeutics Inc. (EIKN)
Itraconazole	BioNTech SE (BNTX)
ivonescimab	REVOLUTION MEDICINES, INC. (RVMD)
jab-23e73	X4 Pharmaceuticals, Inc (XFOR)
lee011	Novartis AG (NVS)
lenvatinib	Innovation Pharmaceuticals Inc. (IPIX)
mdna11	Medicenna Therapeutics Corp. (MDNAF)
mfolfox6	AC Immune SA (ACIU)
miransertib	ARQULE INC (ARQL)
monalizumab	AC Immune SA (ACIU)
Neladalkib	Nuvalent, Inc. (NUVL)
oral repotrectinib	Turning Point Therapeutics, Inc. (TPTX)
oral repotrectinib	TG THERAPEUTICS, INC. (TGTX)
Paroxetine	BioNTech SE (BNTX)
phase 1b	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
platinum-based doublet chemotherapy	VERTEX PHARMACEUTICALS INC / MA (VRTX)
platinum-based doublet chemotherapy	REGENERON PHARMACEUTICALS, INC. (REGN)
Pumitamig	BioNTech SE (BNTX)
REC-617	RECURSION PHARMACEUTICALS, INC. (RXRX)
regn7075	REGENERON PHARMACEUTICALS, INC. (REGN)
regn7075	VERTEX PHARMACEUTICALS INC / MA (VRTX)
rezatapopt	PMV Pharmaceuticals, Inc. (PMVP)
sgn1	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
son-1010	SONNET BIOTHERAPEUTICS HOLDINGS, INC. (BURG)
sqz-eapc-hpv	SQZ Biotechnologies Co (SQZB)
TNG462	Tango Therapeutics, Inc. (TNGX)
TNG908	Tango Therapeutics, Inc. (TNGX)
toripalimab	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
trifluridine-tipiracil	VERTEX PHARMACEUTICALS INC / MA (VRTX)
trifluridine-tipiracil	REGENERON PHARMACEUTICALS, INC. (REGN)
ttx-mc138	Transcode Therapeutics, Inc. (RNAZ)
tulmimetostat	Novartis AG (NVS)
Tulmimetostat	Novartis AG (NVS)
vilastobart	Xilio Therapeutics, Inc. (XLO)
XmAb662	Xencor Inc (XNCR)
xtx202	Xilio Therapeutics, Inc. (XLO)
xtx301	Xilio Therapeutics, Inc. (XLO)

Phase 2/Phase 3(3)

Drug	Company
eik1004	Eikon Therapeutics Inc. (EIKN)
eik1004-001	Eikon Therapeutics Inc. (EIKN)
eik1005	Eikon Therapeutics Inc. (EIKN)

Phase 4(7)

Drug	Company
axitinib	Incyte Corp. (INCY)
BAT8008 for Injection	Merus N.V. (MRUS)
bms-986484	BRISTOL MYERS SQUIBB CO (BMY)
bms-986500	BRISTOL MYERS SQUIBB CO (BMY)
BMS-986504	BRISTOL MYERS SQUIBB CO (BMY)
nazartinib	NOVARTIS AG (NVSEF)
osimertinib	NOVARTIS AG (NVSEF)

Compare drugs

an2025 vs anticancer agents an2025 vs azd3470 an2025 vs AZD5069

Frequently asked questions

How many drugs are in development for Advanced Solid Tumor?

BioSniper tracks 316 drugs in development for Advanced Solid Tumor across 99 companies.

How many clinical trials target Advanced Solid Tumor?

There are 116 clinical trials targeting Advanced Solid Tumor tracked by BioSniper.

Deep-dive into Advanced Solid Tumor

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis